Ken Takahashi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ken Takahashi has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Kosaku Kinoshita
Division of Emergency and Critical Care Medicine, Department of Acute Medicine, Nihon University School of Medicine, 30-1 Oyaguchi Kamimachi, Itabashi-ku, Tokyo 173-8610, Japan
6 shared publications - Junko Yamaguchi
Division of Emergency and Critical Care Medicine, Department of Acute Medicine, Nihon University School of Medicine, 30-1 Oyaguchi Kamimachi, Itabashi-ku, Tokyo 173-8610, Japan
4 shared publications - Toru Imai
Department of Pharmacy, Nihon University Itabashi Hospital, Tokyo 173-8610, Japan
4 shared publications - Tsukasa Kuwana
Division of Emergency and Critical Care Medicine, Department of Acute Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan
4 shared publications - Yurina Yamaya
Division of Emergency and Critical Care Medicine, Department of Acute Medicine, Nihon University School of Medicine, Tokyo 173-8610, Japan
4 shared publications - Hayato Nakabayashi
Division of Emergency and Critical Care Medicine, Department of Acute Medicine, Nihon University School of Medicine, 30-1 Oyaguchi Kamimachi, Itabashi-ku, Tokyo 173-8610, Japan
3 shared publications
Latest Publications
- Open Access
- 19 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 9077
Association of the Early Best Response ROX Index and Admission Erector Spinae Muscle Area with High-Flow Nasal Cannula Failure: A Single-Center Retrospective Cohort Study
Background/Objectives: Failure to recognize high-flow nasal cannula (HFNC) failure early may delay intubation and worsen clinical outcomes. We investigated whether the early physiological response to HFNC and erector spinae muscle (ESM) area at admission were associated with HFNC failure in pneumonia-related acute respiratory failure. Methods: This single-center retrospective observational cohort study included adults who received HFNC within 24 h of intensive care unit admission between 2019 and 2023. HFNC failure was defined as intubation within 7 days. The Respiratory Rate–Oxygenation (ROX) index was measured before HFNC initiation. For days 1 and 2, the best response ROX index was retrospectively defined as the ROX value corresponding to the highest PaO2/ fraction of inspired oxygen ratio within each 24 h assessment window, rather than as a measurement obtained at a prespecified time point. The ESM area at T12 was measured on admission. Longitudinal changes in the ROX index and factors associated with HFNC failure were evaluated. Results: Among 94 patients, 21 experienced HFNC failure. The admission ROX index did not differ significantly between the groups (3.4 versus 3.6). The median best response ROX indices in the success and failure groups were 10.7 versus 6.6 on day 1 and 10.5 versus 6.4 on day 2. ROX improvement was significantly smaller in the failure group on both days. The day 1 best response ROX index had an area under the receiver operating characteristic curve of 0.731 (95% confidence interval [CI], 0.611–0.851). In the primary analysis using Firth penalized logistic regression (85 patients, including 17 HFNC failures), a lower day 1 best response ROX index (adjusted odds ratio [OR] per unit increase, 0.818; 95% CI, 0.692–0.931) and a smaller admission ESM area (adjusted OR per 100 mm2 increase, 0.939; 95% CI, 0.872–0.999) were associated with HFNC failure. Conclusions: The day 1 best response ROX index and admission ESM area were associated with HFNC failure. However, their clinical utility remains uncertain, and prospective multicenter studies with standardized assessment protocols and external validation are warranted.
- 19 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (22) , 9077
Open AccessAssociation of the Early Best Response ROX Index and Admission Erector Spinae Muscle Area with High-Flow Nasal Cannula Failure: A Single-Center Retrospective Cohort Study
Background/Objectives: Failure to recognize high-flow nasal cannula (HFNC) failure early may delay intubation and worsen clinical outcomes. We investigated whether the early physiological response to HFNC and erector spinae muscle (ESM) area at admission were associated with HFNC failure in pneumonia-related acute respiratory failure. Methods: This single-center retrospective observational cohort study included adults who received HFNC within 24 h of intensive care unit admission between 2019 and 2023. HFNC failure was defined as intubation within 7 days. The Respiratory Rate–Oxygenation (ROX) index was measured before HFNC initiation. For days 1 and 2, the best response ROX index was retrospectively defined as the ROX value corresponding to the highest PaO2/ fraction of inspired oxygen ratio within each 24 h assessment window, rather than as a measurement obtained at a prespecified time point. The ESM area at T12 was measured on admission. Longitudinal changes in the ROX index and factors associated with HFNC failure were evaluated. Results: Among 94 patients, 21 experienced HFNC failure. The admission ROX index did not differ significantly between the groups (3.4 versus 3.6). The median best response ROX indices in the success and failure groups were 10.7 versus 6.6 on day 1 and 10.5 versus 6.4 on day 2. ROX improvement was significantly smaller in the failure group on both days. The day 1 best response ROX index had an area under the receiver operating characteristic curve of 0.731 (95% confidence interval [CI], 0.611–0.851). In the primary analysis using Firth penalized logistic regression (85 patients, including 17 HFNC failures), a lower day 1 best response ROX index (adjusted odds ratio [OR] per unit increase, 0.818; 95% CI, 0.692–0.931) and a smaller admission ESM area (adjusted OR per 100 mm2 increase, 0.939; 95% CI, 0.872–0.999) were associated with HFNC failure. Conclusions: The day 1 best response ROX index and admission ESM area were associated with HFNC failure. However, their clinical utility remains uncertain, and prospective multicenter studies with standardized assessment protocols and external validation are warranted.
- Open Access
- 15 July 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (3) , 394
Vasopressor Dosing Trajectories in Septic Shock According to Initial Antimicrobial Susceptibility and Infection Source Concordance: A Retrospective Observational Study
Background/Objectives: Septic shock carries high mortality. Although guidelines recommend early empiric antibiotics, early identification of the infection source and selection of appropriate initial antibiotic therapy remain challenging. This study examined whether vasopressor trajectories, quantified as norepinephrine equivalent (NEE), differed according to initial antimicrobial susceptibility and concordance between presumed and final infection sources. Methods: This single-center retrospective observational study included adults with Sepsis-3 septic shock admitted to the intensive care unit between 2017 and 2023. Patients were classified into the appropriate-management group when the initial antibiotic therapy covered the subsequently identified causative pathogen and the initially presumed infection source was concordant with the final infection source; all others were classified into the inappropriate-management group. Primary outcomes were Max NEE duration and the times from Max NEE to 75%, 50%, 25%, and discontinuation of NEE. Results: Among 132 patients analyzed, 101 were classified into the appropriate-management group and 31 into the inappropriate-management group. Max NEE duration was shorter in the appropriate-management group (median (IQR), 4 (2–7) h vs. 6 (3–20) h; p = 0.0100) and remained shorter after excluding deaths during the Max NEE period (n = 119; 6 (2–11) h vs. 11 (5–14) h; p = 0.0314). Time to NEE reduction from Max NEE was shorter in the appropriate-management group, with significant differences at 75% (7 (4–13) h vs. 13 (9–23) h; p = 0.0066) and 25% (19 (13–29) h vs. 31 (16–46) h; p = 0.0247). Conclusions: Prolonged Max NEE duration and delayed NEE reduction were associated with inadequate coverage by initial antibiotic therapy or discordant infection source identification in this selected cohort. Vasopressor trajectories may help prompt reassessment of antibiotic therapy and infection source evaluation.
- 15 July 2026
- Published by MDPI AG in Medical Sciences
- Vol. 14 (3) , 394
Open AccessVasopressor Dosing Trajectories in Septic Shock According to Initial Antimicrobial Susceptibility and Infection Source Concordance: A Retrospective Observational Study
Background/Objectives: Septic shock carries high mortality. Although guidelines recommend early empiric antibiotics, early identification of the infection source and selection of appropriate initial antibiotic therapy remain challenging. This study examined whether vasopressor trajectories, quantified as norepinephrine equivalent (NEE), differed according to initial antimicrobial susceptibility and concordance between presumed and final infection sources. Methods: This single-center retrospective observational study included adults with Sepsis-3 septic shock admitted to the intensive care unit between 2017 and 2023. Patients were classified into the appropriate-management group when the initial antibiotic therapy covered the subsequently identified causative pathogen and the initially presumed infection source was concordant with the final infection source; all others were classified into the inappropriate-management group. Primary outcomes were Max NEE duration and the times from Max NEE to 75%, 50%, 25%, and discontinuation of NEE. Results: Among 132 patients analyzed, 101 were classified into the appropriate-management group and 31 into the inappropriate-management group. Max NEE duration was shorter in the appropriate-management group (median (IQR), 4 (2–7) h vs. 6 (3–20) h; p = 0.0100) and remained shorter after excluding deaths during the Max NEE period (n = 119; 6 (2–11) h vs. 11 (5–14) h; p = 0.0314). Time to NEE reduction from Max NEE was shorter in the appropriate-management group, with significant differences at 75% (7 (4–13) h vs. 13 (9–23) h; p = 0.0066) and 25% (19 (13–29) h vs. 31 (16–46) h; p = 0.0247). Conclusions: Prolonged Max NEE duration and delayed NEE reduction were associated with inadequate coverage by initial antibiotic therapy or discordant infection source identification in this selected cohort. Vasopressor trajectories may help prompt reassessment of antibiotic therapy and infection source evaluation.
- Open Access
- 15 January 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (1) , 88
Impact of High-Dose Cefepime During the Initial 48 h on Intensive Care Unit Survival in Sepsis: A Retrospective Observational Study
Background/Objectives: Sepsis is a life-threatening condition associated with high mortality. Optimal dosing strategies for β-lactam antibiotics in sepsis remain controversial, particularly in patients with renal impairment. Cefepime (CFPM) is widely used as empiric therapy; however, its appropriate initial dosing in critically ill patients is unclear. This study aimed to evaluate whether high-dose CFPM administration during the first 48 h improves survival in patients with sepsis, irrespective of renal function. Methods: This single-center, retrospective, observational study included adult intensive care unit (ICU) patients with sepsis who received CFPM as initial therapy between January 2017 and December 2024. Patients were categorized into High-dose (12 g within 48 h; 2 g every 8 h) and Low-dose (p = 0.0066). This association remained consistent in the 1% trimmed IPTW analysis (OR 4.07, 95% CI 1.19–13.97, p = 0.0256). Stabilized IPTW yielded a similar effect estimate, though without statistical significance (OR 5.43, 95% CI 0.72–41.16, p = 0.1017). Overall, results were consistent in direction and magnitude across models. Conclusions: High-dose CFPM administration during the initial 48 h was associated with improved ICU survival in patients with sepsis, independent of renal function.
- 15 January 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (1) , 88
Open AccessImpact of High-Dose Cefepime During the Initial 48 h on Intensive Care Unit Survival in Sepsis: A Retrospective Observational Study
Background/Objectives: Sepsis is a life-threatening condition associated with high mortality. Optimal dosing strategies for β-lactam antibiotics in sepsis remain controversial, particularly in patients with renal impairment. Cefepime (CFPM) is widely used as empiric therapy; however, its appropriate initial dosing in critically ill patients is unclear. This study aimed to evaluate whether high-dose CFPM administration during the first 48 h improves survival in patients with sepsis, irrespective of renal function. Methods: This single-center, retrospective, observational study included adult intensive care unit (ICU) patients with sepsis who received CFPM as initial therapy between January 2017 and December 2024. Patients were categorized into High-dose (12 g within 48 h; 2 g every 8 h) and Low-dose (p = 0.0066). This association remained consistent in the 1% trimmed IPTW analysis (OR 4.07, 95% CI 1.19–13.97, p = 0.0256). Stabilized IPTW yielded a similar effect estimate, though without statistical significance (OR 5.43, 95% CI 0.72–41.16, p = 0.1017). Overall, results were consistent in direction and magnitude across models. Conclusions: High-dose CFPM administration during the initial 48 h was associated with improved ICU survival in patients with sepsis, independent of renal function.
- Open Access
Changes in Body Composition During Intensive Care Unit Stay and Outcomes in Patients with Severe COVID-19 Pneumonia: A Retrospective Cohort Study
This single-center retrospective observational study investigated the association between changes in body composition during hospitalization and outcomes in patients with severe coronavirus disease (COVID-19) pneumonia. Body composition was assessed using chest computed tomography (CT) within 3 days of intensive care unit admission and follow-up CT within 14 days. The study population comprised 89 adult patients, among whom 57 survived. The median APACHE II score on admission was 16. Initial CT scans showed that the iliopsoas muscle volume, sum of the pectoralis major and minor muscle areas, and erector spinae muscle (ESM) area were significantly larger in survivors than in non-survivors (p = 0.019, 0.011, and 0.001, respectively). Subcutaneous fat tissue (SAT) volume was higher in survivors (p = 0.003), and the rate of change in the SAT volume was lower in survivors (p = 0.043). Multivariate logistic regression analysis revealed that a high APACHE II score (OR: 0.834, 95% CI: 0.741–0.938, p = 0.002) and small ESM area (OR: 1.001, 95% CI: 1.000–1.002, p = 0.031) were independent predictors of mortality. In conclusion, the loss of supporting respiratory muscles, particularly ESM, may play a critical role beyond general acute sarcopenia, and the preserved SAT in non-survivors may reflect abnormal glucose metabolism due to severe inflammation.
Open AccessChanges in Body Composition During Intensive Care Unit Stay and Outcomes in Patients with Severe COVID-19 Pneumonia: A Retrospective Cohort Study
This single-center retrospective observational study investigated the association between changes in body composition during hospitalization and outcomes in patients with severe coronavirus disease (COVID-19) pneumonia. Body composition was assessed using chest computed tomography (CT) within 3 days of intensive care unit admission and follow-up CT within 14 days. The study population comprised 89 adult patients, among whom 57 survived. The median APACHE II score on admission was 16. Initial CT scans showed that the iliopsoas muscle volume, sum of the pectoralis major and minor muscle areas, and erector spinae muscle (ESM) area were significantly larger in survivors than in non-survivors (p = 0.019, 0.011, and 0.001, respectively). Subcutaneous fat tissue (SAT) volume was higher in survivors (p = 0.003), and the rate of change in the SAT volume was lower in survivors (p = 0.043). Multivariate logistic regression analysis revealed that a high APACHE II score (OR: 0.834, 95% CI: 0.741–0.938, p = 0.002) and small ESM area (OR: 1.001, 95% CI: 1.000–1.002, p = 0.031) were independent predictors of mortality. In conclusion, the loss of supporting respiratory muscles, particularly ESM, may play a critical role beyond general acute sarcopenia, and the preserved SAT in non-survivors may reflect abnormal glucose metabolism due to severe inflammation.
- Open Access
- 4 November 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (21) , 6618
The Time Course of Catecholamine Dose Reduction in Septic Shock as a Predictor of Bacterial Susceptibility to Empiric Antimicrobial Therapy: A Retrospective Observational Study
Background/Objectives: The 28-day mortality rate for septic shock is high, necessitating rapid and effective empiric antimicrobial therapy. In this study, we investigate whether the rate of catecholamine dose reduction in septic shock can indicate bacterial susceptibility to initial antimicrobial therapy or not. Methods: This retrospective observational study involved 108 adult patients with bacteraemia and septic shock admitted to the intensive care unit of Nihon University Itabashi Hospital between January 2017 and December 2023. They were classified into the Susceptible or Resistant groups based on the bacteria’s susceptibility to the initial empiric antimicrobial therapy. Catecholamine dosages were converted to norepinephrine equivalent (NEE) scores, with the time course from the peak to the end of administration measured at NEE reductions. Results: Of the 108 patients, 94 were in the Susceptible group and 14 in the Resistant group. The Susceptible group showed faster reductions in catecholamine doses: the time to reduce the dose from the maximum NEE to 25% was 19 vs. 49.5 h (p = 0.0057), and to 0%, it was 29 vs. 54 h (p = 0.0475). The time to reduce the dose from the maximum NEE to 75% was 8 vs. 12.5 h (p = 0.0733), and to 50% it was 13 vs. 21.5 h (p = 0.1081). Conclusions: In septic shock with bacteraemia, a faster catecholamine dose reduction indicates bacterial susceptibility to the initial empiric antibiotics. This reduction rate can serve as an early clinical indicator of the appropriate initial empiric therapy.
- 4 November 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (21) , 6618
Open AccessThe Time Course of Catecholamine Dose Reduction in Septic Shock as a Predictor of Bacterial Susceptibility to Empiric Antimicrobial Therapy: A Retrospective Observational Study
Background/Objectives: The 28-day mortality rate for septic shock is high, necessitating rapid and effective empiric antimicrobial therapy. In this study, we investigate whether the rate of catecholamine dose reduction in septic shock can indicate bacterial susceptibility to initial antimicrobial therapy or not. Methods: This retrospective observational study involved 108 adult patients with bacteraemia and septic shock admitted to the intensive care unit of Nihon University Itabashi Hospital between January 2017 and December 2023. They were classified into the Susceptible or Resistant groups based on the bacteria’s susceptibility to the initial empiric antimicrobial therapy. Catecholamine dosages were converted to norepinephrine equivalent (NEE) scores, with the time course from the peak to the end of administration measured at NEE reductions. Results: Of the 108 patients, 94 were in the Susceptible group and 14 in the Resistant group. The Susceptible group showed faster reductions in catecholamine doses: the time to reduce the dose from the maximum NEE to 25% was 19 vs. 49.5 h (p = 0.0057), and to 0%, it was 29 vs. 54 h (p = 0.0475). The time to reduce the dose from the maximum NEE to 75% was 8 vs. 12.5 h (p = 0.0733), and to 50% it was 13 vs. 21.5 h (p = 0.1081). Conclusions: In septic shock with bacteraemia, a faster catecholamine dose reduction indicates bacterial susceptibility to the initial empiric antibiotics. This reduction rate can serve as an early clinical indicator of the appropriate initial empiric therapy.
- Open Access
- 9 September 2024
- Published by MDPI AG in Preprints.org
The Time Course of Catecholamine Dose Reduction in Septic Shock as a Predictor of Bacterial Susceptibility to Empiric Antimicrobial Therapy: A Retrospective Observational Study
Background/Objectives: The 28-day mortality rate for septic shock is high, necessitating rapid and effective empiric antimicrobial therapy. This study investigates whether the rate of catecholamine dose reduction in septic shock can indicate bacterial susceptibility to initial antimicrobial therapy. Methods: This retrospective observational study involved 108 adult patients with bacteraemia and septic shock admitted at the intensive care unit of Nihon University Itabashi Hospital between January 2017 and December 2023. They were classified into the Susceptible or Resistant group based on the bacteria’s susceptibility to the initial empiric antimicrobial therapy. Catecholamine dosages were converted to norepinephrine equivalent (NEE) scores, with the time course from peak to end of administration measured at NEE reductions. Results: Of the 108 patients, 94 were in the Susceptible group and 14 in the Resistant group. The Susceptible group showed faster reductions in catecholamine doses: time to reduce the dose from the maximum NEE to 25% was 19 vs. 49.5 hours (p = 0.0057); and 0%, 29 vs. 54 hours (p = 0.0475). Conclusions: In septic shock with bacteraemia, faster catecholamine dose reduction indicates bacterial susceptibility to initial empiric antibiotics. This reduction rate can serve as an early clinical indicator of appropriate initial empiric therapy.
- 9 September 2024
- Published by MDPI AG in Preprints.org
Open AccessThe Time Course of Catecholamine Dose Reduction in Septic Shock as a Predictor of Bacterial Susceptibility to Empiric Antimicrobial Therapy: A Retrospective Observational Study
Background/Objectives: The 28-day mortality rate for septic shock is high, necessitating rapid and effective empiric antimicrobial therapy. This study investigates whether the rate of catecholamine dose reduction in septic shock can indicate bacterial susceptibility to initial antimicrobial therapy. Methods: This retrospective observational study involved 108 adult patients with bacteraemia and septic shock admitted at the intensive care unit of Nihon University Itabashi Hospital between January 2017 and December 2023. They were classified into the Susceptible or Resistant group based on the bacteria’s susceptibility to the initial empiric antimicrobial therapy. Catecholamine dosages were converted to norepinephrine equivalent (NEE) scores, with the time course from peak to end of administration measured at NEE reductions. Results: Of the 108 patients, 94 were in the Susceptible group and 14 in the Resistant group. The Susceptible group showed faster reductions in catecholamine doses: time to reduce the dose from the maximum NEE to 25% was 19 vs. 49.5 hours (p = 0.0057); and 0%, 29 vs. 54 hours (p = 0.0475). Conclusions: In septic shock with bacteraemia, faster catecholamine dose reduction indicates bacterial susceptibility to initial empiric antibiotics. This reduction rate can serve as an early clinical indicator of appropriate initial empiric therapy.